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Nucleocytoplasmic Transport of Preintegration Complex
and Viral mRNA in Retrovirus-Infected Cells
Active transport of proteins and mRNAs between the nucleus and cytoplasm is a major process in
eukaryotic cells. Recently,  factors that recognize transport substrates and mediate nuclear import  or
export have been characterized, revealing interactions that target substrates to the nuclear pore
complexes, through which translocation occurs.  In the first half of the report, nuclear import of the
human immunodeficiency virus 1 (HIV-1) preintegration complex (PIC) is discussed. The second half
describes recent information on the mechanistic details of nuclear export of viral mRNA so-called  Rev-
dependent trans-activation of viral genes.
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Scope of research
  This laboratory was founded in 1994 with the aim of linking (bio)chemical research and clinical medicine. Thus, the scope of our
research encompasses the structure, function and regulation of various biomolecules, the pathophysiological significance of
bioreactions in relation to human diseases, and the application of molecular techniques to clinical diagnosis and therapy.
  Our current interest is focused on poly(ADP-ribosyl)ation, nucleocytoplasmic transport of proteins in association with leukemo-
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The ability of HIV-1 to transport its preintegration
complex (PIC) into the nucleus of an infected cell during
interphase is a unique feature (1). A basic-type nuclear
localization signal (NLS) was identified in the N-
terminal region of the HIV-1 matrix protein (MA) and
was found to regulate viral nuclear import and infection.
Genetic analysis also implicated viral protein Vpr in the
process of nuclear import of the HIV-1 PIC. But this
protein does not have a classical NLS, and its role in
nuclear import remained unclear until recently.
Recent studies identified that Vpr controls nuclear
import through an importin α-independent mechanism
(1). This result was consistent with resistance of Vpr-
regulated viral nuclear import to competition by NLS
peptides. The binding site of Vpr on importin α does not
appear to overlap  with the NLS-binding sites. In fact,
importin α, Vpr, and MA can assemble into a trimer. As
a result of Vpr binding to importin α, the affinity of
interaction between the NLS and importin α was
increased approximately 10-fold. This mechanism may
be instrumental in increasing the karyophilic potential of
the HIV-1 PIC.
It appears, therefore, that nuclear import of the HIV-1
PIC is controlled by two viral proteins, Vpr and MA (Fig.
1). While MA contributes its NLS which connect the PIC
to importin α and cellular import machinery, Vpr
functions as an enhancer of the MA-importin α inter-
action. In addition, Vpr was found to bind nucleoporins
and was suggested on these grounds to function as an
importin β analog.  Although this hypothesis is
consistent with the role of Vpr in docking of the HIV-1
PIC to the nuclear envelope, it is hard to imagine that a
small protein, such as Vpr (with a molecular mass of only
14 kDa), can perform the function of a 97-kDa importin
β. We therefore favor the notion that the effects of Vpr
are mediated through the importin α/β pathway.
Inactivation of either partner in the HIV-1 nuclear import
(i.e., MA, Vpr, or  importin α/β) results in the loss of
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Figure 1.   A model of nuclear import of the HIV-1 PIC.
Figure 2.   Mechanism of Rev-dependent nuclear export of vi-
ral mRNA.
The molecular details behind CRM1-mediated Rev
export are still ambiguous. Our studies have been
focused on the assembly of the RRE RNA-Rev-CRM1-
RanGTP complex in greater detail in vitro. CRM1
interacts directly with full-length Rev independently  of
the conserved leucine residues within the core of the
NES and the presence of RanGTP. This Ran-independent
interaction is LMB insensitive. In contrast, formation of
the ternary Rev-CRM1-RanGTP complex is highly
sensitive to NES mutations and is readily dissociated in
vitro by LMB or by hydrolysis of Ran GTP.
As shown in Figure 2, Rev utilizes the cellular shuttle
service to be imported into the nucleus as the Rev-B23
complex via the NLS/RRE-binding domain. As the RRE
RNA has higher affinity for Rev than B23, the nuclear-
imported complex is specifically dissociated by the RRE
RNA. The RRE RNA-Rev complex binds to CRM1 via
NES cooperatively with RanGTP and is subsequently
translocated through the nuclear pore complex. In the
cytoplasm, the RRE RNA-Rev-CRM1-RanGTP
complex dissociates when Ran hydrolyzes GTP under
the influence of RanBP or RanGAP.
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import function and virus inability to establish efficient
infection in primary cells. These proteins, therefore,
present an attractive target for development of novel
anti-HIV therapeutics.
HIV-1 encodes the regulatory protein Rev, which is
absolutely required for viral replication (2,3). Rev
promotes the nuclear export of incompletely spliced
HIV-1 mRNA species containing the Rev response element
(RRE). Rev interacts directly with a stem-loop within the
RRE. Rev is a 116-amino acids phosphoprotein that has
been shown to continuously shuttle between the nucleus
and cytoplasm. Nuclear import of Rev is mediated by
NLS embedded in the the RRE-binding domain. The
NLS of Rev has been reported to associate with the
conventional importin α/β heterodimer as well as  a
nucleolar shuttle protein B23. Nuclear export of Rev is
mediated by the nuclear export signal (NES), which
contains a conserved stretch of characteristically spaced
leucine residues.
Recently, the highly conserved CRM1 protein was
identified as a functional nuclear receptor for Rev NES
and hence the protein was also renamed exportin 1 (4,5).
Independent experiments showed that overexpression of
CRM1 increased the export of nuclear-injected Rev
protein. Moreover, the cytotoxin leptomycin B (LMB)
inhibited in vivo export of both Rev protein and Rev-
dependent RRE RNA export. This effect  by LMB is
direct because LMB binds to CRM1, and , in yeast,
resistance to LMB maps to crm 1 gene. Further support
for CRM1 being an export receptor for NES-containing
proteins is based on the observation that N-terminal
region of CRM1 is homologous to the RanGTP-binding
domain of importin β, placing CRM1 in the family of
RanGTP-binding proteins that includes other known and
putative import and export receptors. CRM1 has also
been found in complex with at least two proteins
associated with the human nuclear pore complex, namely
the nucleoporins CAN/Nup214 and Nup88, and yeast
two-hybrid analysis have demonstrated interactions
between CRM1 and several nucleoporins as well as Rev
and Ran (6).
